[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,752,257
  • Shares Outstanding, K 58,040
  • Annual Sales, $ 718,950 K
  • Annual Income, $ -38,550 K
  • EBIT $ 35 M
  • EBITDA $ 125 M
  • 60-Month Beta 0.54
  • Price/Sales 3.88
  • Price/Cash Flow 12.77
  • Price/Book 2.60

Options Overview Details

View History
  • Implied Volatility 57.44% (-1.01%)
  • Historical Volatility 30.16%
  • IV Percentile 90%
  • IV Rank 77.15%
  • IV High 66.99% on 09/26/25
  • IV Low 25.20% on 08/12/25
  • Expected Move (DTE 31) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 4.51
  • Today's Open Interest 1,867
  • Open Int (30-Day) 1,825
  • Expected Range 47.42 to 47.42

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.30
  • Number of Estimates 1
  • High Estimate $0.30
  • Low Estimate $0.30
  • Prior Year $0.78
  • Growth Rate Est. (year over year) -61.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.09 +7.55%
on 06/22/26
51.37 -7.69%
on 07/09/26
+3.04 (+6.85%)
since 06/18/26
3-Month
42.45 +11.71%
on 06/16/26
52.96 -10.46%
on 05/06/26
-3.83 (-7.47%)
since 04/20/26
52-Week
32.21 +47.24%
on 07/21/25
59.68 -20.54%
on 02/25/26
+15.08 (+46.63%)
since 07/18/25

Most Recent Stories

More News
1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm

1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm

TT : 472.69 (+0.97%)
FORM : 109.67 (+4.14%)
SUPN : 47.38 (-0.08%)
1 Growth Stock to Stash and 2 We Turn Down

1 Growth Stock to Stash and 2 We Turn Down

SHOP : 122.09 (-1.92%)
SUPN : 47.38 (-0.08%)
ESTC : 62.27 (-0.75%)
Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD

Qelbree remains the first novel, non-stimulant ADHD medication approved in over a decade and is the only ADHD treatment with serotonin (5-HT 2C ) pharmacodynamics approved in its FDA product labeling....

SUPN : 47.38 (-0.08%)
Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest

Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest

SUPN : 47.38 (-0.08%)
3 of Wall Street’s Favorite Stocks We Approach with Caution

3 of Wall Street’s Favorite Stocks We Approach with Caution

COLL : 35.31 (-0.65%)
SUPN : 47.38 (-0.08%)
REAX : 2.03 (+1.00%)
3 Reasons to Avoid SUPN and 1 Stock to Buy Instead

3 Reasons to Avoid SUPN and 1 Stock to Buy Instead

SUPN : 47.38 (-0.08%)
1 Cash-Heavy Stock on Our Watchlist and 2 Facing Challenges

1 Cash-Heavy Stock on Our Watchlist and 2 Facing Challenges

DT : 44.28 (-0.96%)
SUPN : 47.38 (-0.08%)
ERII : 8.48 (-1.62%)
Supernus Pharmaceuticals to Participate in June Investor Conferences

ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...

SUPN : 47.38 (-0.08%)
3 Stocks Under $50 with Open Questions

3 Stocks Under $50 with Open Questions

SUPN : 47.38 (-0.08%)
WASH : 38.14 (+5.01%)
IART : 18.91 (+0.11%)
3 Small-Cap Stocks That Concern Us

3 Small-Cap Stocks That Concern Us

SOUN : 6.38 (+1.11%)
SUPN : 47.38 (-0.08%)
OCSL : 12.06 (-0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

3rd Resistance Point 49.87
2nd Resistance Point 49.33
1st Resistance Point 48.38
Last Price 47.38
1st Support Level 46.88
2nd Support Level 46.34
3rd Support Level 45.38

See More

52-Week High 59.68
Fibonacci 61.8% 49.18
Last Price 47.38
Fibonacci 50% 45.94
Fibonacci 38.2% 42.70
52-Week Low 32.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.